INGRAM DOUGLAS S

Average Profitability
4.37%
Insider Buys Quantity
8
Insider Buys Sum
$19.03M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of INGRAM DOUGLAS S

The largest purchase of all time was on 2018-10-30 and amounted to 33390 shares of Sarepta Therapeutics, Inc. for $4.02M.

Biography of INGRAM DOUGLAS S

No biography is available at this moment.

2023-11-03PurchaseSarepta Therapeutics, Inc.
SRPT
President & CEO
25,225
0.0275%
$79.36$2M+59.43%
2021-11-17PurchaseSarepta Therapeutics, Inc.
SRPT
President & CEO
25,026
0.0309%
$79.94$2M+3.14%
2020-07-20PurchaseRelay Therapeutics, Inc.
RLAY
director
50,000
0.0327%
$20.00$1M-11.36%
2019-08-12PurchaseSarepta Therapeutics, Inc.
SRPT
President & CEO
16,252
0.0217%
$123.07$2M-5.04%
2018-10-30PurchaseSarepta Therapeutics, Inc.
SRPT
President & CEO
33,390
0.0488%
$120.39$4.02M-2.6%
2018-08-15PurchaseSarepta Therapeutics, Inc.
SRPT
President & CEO
32,000
0.0482%
$125.26$4.01M+1.02%
2017-11-08PurchaseSarepta Therapeutics, Inc.
SRPT
President & CEO
38,138
0.0648%
$52.44$2M+72.12%
2017-07-27PurchaseSarepta Therapeutics, Inc.
SRPT
President & CEO
47,058
0.0801%
$42.50$2M+52%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.